Aberrant activation of the canonical WNT pathway is considered an essential early event in the colorectal carcinogenesis, and overexpression of WNT2 has been reported in esophageal, colorectal and gastric cancers (13–15). This evidence concerns the gene WNT2 and gastric cancer.